BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.

CEO

Dr. Zaki Rakib Ph.D.

Country

ISIN

CA09076J2074

Listings

0 Comments

Share your thoughts

FAQ

What is BioHarvest Sciences stock price today?▼

The current price of CNVCD is $6.09 USD — it has increased by +0% in the past 24 hours. Watch BioHarvest Sciences stock price performance more closely on the chart.

What is BioHarvest Sciences stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange BioHarvest Sciences stocks are traded under the ticker CNVCD.

What is BioHarvest Sciences market cap?▼

Today BioHarvest Sciences has the market capitalization of 119.46M

What is BioHarvest Sciences revenue for the last year?▼

BioHarvest Sciences revenue for the last year amounts to 50.38M USD.

What is BioHarvest Sciences net income for the last year?▼

CNVCD net income for the last year is -25.83M USD.

When did BioHarvest Sciences complete a stock split?▼

The last stock split for BioHarvest Sciences was on June 03, 2024 with a ratio of 1:35.

Where is BioHarvest Sciences headquartered?▼

BioHarvest Sciences is headquartered in Vancouver, CA.